FDA warns on counterfeit Adderall


The U.S. Food and Drug Administration (FDA) warned consumers and healthcare professionals on May 29 that a counterfeit version of Teva Pharmaceutical Industries’ Adderall 30 milligram tablets is being sold on the Internet. Adderall, which is approved by the FDA to treat attention deficit hyperactivity disorders (ADHD) and narcolepsy, is a prescription drug classified as a controlled substance.

FDA’s preliminary laboratory tests revealed that the counterfeit version of Teva’s Adderall 30 mg tablets contained the wrong active ingredients. Adderall contains four active ingredients: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate. Instead of those active ingredients, the counterfeit product contained tramadol and acetaminophen, which are ingredients in medicines used to treat acute pain.

Adderall is in short supply due to active pharmaceutical ingredient supply issues, according to the FDA. Teva continues to release product as it becomes available. The agency noted that rogue websites and distributors often target medicines in short supply for counterfeiting.

The counterfeit Adderall tablets are round, white and do not have any type of markings, such as letters or numbers. Any product that resembles the tablets or the packaging (see photo) and claims to be Teva’s Adderall 30 mg tablets should be considered counterfeit, the FDA said. The counterfeit versions of Adderall should be considered as unsafe, ineffective and potentially harmful.

Authentic Adderall 30 mg tablets produced by Teva are round, orange/peach, and scored tablets with “dp” embossed on one side and “30” on the other side of the tablet. Teva’s Adderall 30 mg tablets are packaged only in a 100-count bottle with the National Drug Code (NDC) 0555-0768-02 listed.

Patients who believe they have received counterfeit Adderall should contact the FDA’s Office of Criminal Investigations at 800-551-3989 or online.